- High gross margin of 98.7%
- Bullish trend confirmed on both short and long timeframes
- Highly efficient cash conversion (100% FCF/OCF ratio)
Weaker technical forecast for Vyne Therapeutics Inc as stock downgraded to Hold/Accumulate
(Updated on Jul 02, 2026)
The Vyne Therapeutics Inc stock price fell by -0.162% on the last day (Thursday, 2nd Jul 2026) from $0.681 to $0.680. During the last trading day the stock fluctuated 2.97% from a day low at $0.670 to a day high of $0.690. The price has risen in 6 of the last 10 days and is up by 7.73% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -174 thousand shares and in total, 517 thousand shares were bought and sold for approximately $351.79 thousand.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.25% during the next 3 months and, with a 90% probability hold a price between $0.670 and $0.747 at the end of this 3-month period.
VYNE Signals & Forecast
The Vyne Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.659 and $0.663. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -0.162%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Vyne Therapeutics Inc stock
Vyne Therapeutics Inc finds support from accumulated volume at $0.676 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0199 between high and low, or 2.97%. For the last week the stock has had daily average volatility of 4.45%.
Our recommended stop-loss: $0.653 (-3.92%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (VYNE) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Vyne Therapeutics Inc to open at $0.680, and during the day (based on 14 day Average True Range), to move between $0.666 and $0.693, which gives a possible trading interval of +/-$0.0269 (+/-4.03%) up or down from last closing price. If Vyne Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 4.03% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.681 (0.16%) than the support at $0.676 (0.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Vyne Therapeutics Inc stock A Buy?
Vyne Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.
Current score:
0.747
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 6, 2026 - $0.680 ( 0.0049%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VYNE Performance
Trading levels for VYNE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.700 | 2.93% |
| R2 | 0.692 | 1.81% |
| R1 | 0.688 | 1.12% |
| Price | 0.680 | |
| S1 | 0.672 | -1.11% |
| S2 | 0.668 | -1.80% |
| S3 | 0.660 | -2.92% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.683 | 0.427% |
| R2 | 0.681 | 0.176% |
| R1 | 0.681 | 0.162% |
| Price | 0.680 | |
| S1 | 0.676 | -0.529% |
| S2 | 0.656 | -3.52% |
| S3 | 0.622 | -8.52% |
FAQ
Click here for our free guide on how to buy Vyne Therapeutics Inc Stock.
Buy VYNE